Cirius Therapeutics competitors

Richard A. Hoffman is a CEO at ANCORA PHARMACEUTICALS INC.

• Member of the National Ernst and Young Entrepreneur of the Year Hall of Fame• Inducted into the University of Texas College of Natural Sciences Hall of Honor• Received Ohio University's School of Business Distinguished Business Award• Received Ohio University Konneker Medal, the highest award given to a faculty member or former student for entrepreneurial excellence• Named one of the top 10 Life Sciences CEOs in Texas by the Texas Healthcare and Bioscience InstituteMr. Hawkins is currently the President and CEO of Lumos Pharma, Inc. an early-stage orphan drug company based in Austin, Texas. He currently serves as a Board of Director for SciClone Pharmaceuticals Inc., a NASDAQ listed company (SCLN), a biopharmaceutical company whose lead product Zadaxin, an adjuvant for the influenza vaccine in immunocompromised patients or as an immune stimulant, has been approved in at least 13 countries.In addition he serves as a Board of Director for Cytori Therapeutics, Inc.; a global leader in stem cell research and the use of adipose derived stem and regenerative cells.Rick Hawkins is a member of the National Ernst and Young Entrepreneur of the Year Hall of Fame.Mr. Hawkins was inducted into the Hall of Honor for the College of Natural Sciences at the University of Texas by Dean, Mary Ann Rankin. In 2006 he received Ohio University’s Distinguished Business Achievement Award, and in 2014 was awarded the Konneker Medal, the leading entrepreneurial honor awarded by the University. Rick was named one the top 10 Life Sciences CEO’s in Texas by the Texas Healthcare & Bioscience Institute and was the keynote speaker at BioVenture Showcase 2008.

Biotechnology executive with over 25 years experience in biopharma, genomics, health care, venture capital, management consulting, entrepreneurship, and industrial biotechnology. Strong business and technical background, and proven leadership, communication and organizational skills. Experienced for-profit (public and private) and non-profit board director. Frequent speaker, moderator and panelist.Specialties: Therapeutics, medical devices, drug/device combinations, genomics, proteomics, microbiome, diagnostics, synthetic biology, digital health. Strategic, portfolio and operational planning, project and resource management, strategic marketing, alliance management, business development, clinical operations, product development and commercialization, venture capital, fundraising, entrepreneurship, start-up formation and scale-up. From San Juan, Puerto Rico; mom of three teenagers (no, wait - one of them just turned 20...); runner, SCUBA diver, paddle boarder, rabid fan of golden age as well as modern science fiction, occasionally semi-competent singer, obsessive sea glass collector, and aspiring juggler.Twitter: @ColonGraceEClubhouse: @gracecolonInstagram: gracielaelenacolon

James Fairbairn has 20+ years in senior finance roles with emerging companies. He is a Chartered Professional Accountant, having obtained his CPA designation in 1987 and is an Institute-certified Director. Jim holds a Bachelor of Arts from the University of Western Ontario. He is a director of several junior listed companies.